Rare Disease Report

American Society of Clinical Oncology 2018

Pauline Funchain, MD, highlights how humility may be one of the best characteristics in medicine right now.
Pauline Funchain MD, shares how artificial intelligence may serve as a potential breakthrough for treating rare diseases in the future. 
E. Anders Kolb, MD, discusses the exciting possibilities of using genomic technologies to stratify pediatric cancer patients.
Pauline Funchain MD, explains how better understanding of genetics can help shape future treatments for rare cancers.
Manmeet Ahluwalia, MD, discusses the challenges patients and providers face when it comes to rare cancers.
E. Anders Kolb, MD, outlines the challenges in diagnosing pediatric cancers and explains how molecular events define disease outcomes. 
The FDA has granted a breakthrough therapy for atezolizumab Tin combination with bevacizumab for the treatment of advanced or metastatic hepatocellular carcinoma.
E. Anders Kolb, MD, emphasizes the difference between pediatric and adult cancers and the need to develop new treatments developed specifically for children.
Pauline Funchain, MD, discusses the use of multiplex germline testing for rare diseases and cancers and explains the benefits of uncovering genetic factors.
Owen A. O’Connor, MD, PhD, outlines the importance of clinical trials and reviewed strides made in lymphoma treatments. 
The 2018 American Society of Clinical Oncology (ASCO) Annual Meeting was hosted from June 1-5, 2018 in Chicago, Illinois, and was directed toward the world’s leading oncology professionals. Those in attendance gained valuable insight from some of the most esteemed specialists in the field, and Rare Disease Report is providing readers who were unable to travel to Chicago with the most intensive information regarding new research from clinical trials evaluating new and emerging therapies, as well as ongoing controversies throughout the rare disease community.
 
The ASCO Conference Coverage page at Rare Disease Report has the latest related resources from ASCO 2018, including key developments from presentations pertaining to uncommon conditions.
 
For even more from ASCO, content from previous meetings can be found on the ASCO 2017 and ASCO 2016 pages.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.